Embecta Corp. EMBC

About Embecta Corp. (EMBC): stock profile, AI score and financials

Embecta Corp. (EMBC) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores EMBC at 50.9/100 on a composite quality score built from its SEC filings, placing it at rank #1,584 of 2,925 stocks — the bottom half of the AI-ranked universe. EMBC scores in the top quartile across earnings quality (84.2), balance sheet strength (77.9). Areas of concern include institutional flow (2.7) and revenue growth (14.4), which score below median versus the broader universe. Shareholder dilution risk is elevated at 32.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q3 2026), Embecta Corp. reports quarterly revenue of $271.7M, net income of $21.1M, an operating margin of 17.9%. Top institutional holders of EMBC by reported 13-F value include BlackRock, YACKTMAN ASSET MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. EMBC trades on the Nasdaq exchange and files with the SEC under CIK 1872789. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate EMBC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Embecta Corp. directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 1872789 →